BeStock  
Stocks › Biotechnology › GPCR

Structure Therapeutics GPCR

US equityMarket cap rank #3061Biotechnology
$16.13 −$0.99 (-5.78%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $16.69 +3.47%
Open$16.73
Prev close$17.12
Day range$16.06 – $17.08
Volume786.2K
Market cap$1.15B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership105.7%+1.39 pts vs. prior quarter
Institutions holding241-12 vs. prior quarter
Insider trades (recent)28 buys / 22 sellsNet buying
Short interest8.31% of floatDays to cover 6.5 · as of 30 Oct 2026
Short-sale volume share14.1%5-day average of daily volume

Short-sale volume as % of daily volume

4%10%16%23%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$1.01M (11 inflow days, 9 outflow days).

Net flow by order size, last 20 sessions

−$1.7MSuper+$717.8KBig−$791.3KMid+$807.4KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 50.4% of shares outstanding.

Largest holders

  • FMR12.97%
  • Deep Track Capital, LP10.59%
  • Wellington Management Group10.35%
  • Avoro Capital Advisors LLC9.19%
  • Janus Henderson Group plc7.30%
  • BVF Partners L.P.4.72%
  • Morgan Stanley3.95%
  • Morgan Stanley Investment Management Inc.3.95%

By investor type

  • Mutual Fund51.97%
  • Hedge Fund26.85%
  • VC/PE Fund18.30%
  • Public Company5.94%
  • Individual/Insider2.44%
  • Private Company1.26%
  • Government Pension Fund0.61%
  • Sovereign Wealth Fund0.60%

Reported short interest has fallen from 8.53% to 8.31% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
FMR Mutual Fund 2026/Q3 +1,474,365 13.0%
JPMorgan Chase & Co. Public Company 2026/Q3 +542,217 0.8%
Jane Street Group, LLC Private Company 2026/Q3 +232,677 0.3%
abrdn plc Mutual Fund 2026/Q3 +218,869 1.2%
BlackRock Mutual Fund 2026/Q3 +194,797 1.0%
Impresa Management LLC VC/PE Fund 2026/Q3 +69,807 0.5%
RTW Investments, LP Hedge Fund 2026/Q3 +1,607,507 2.3%
OrbiMed Advisors LLC VC/PE Fund 2026/Q3 +733,997 3.1%
Morgan Stanley Public Company 2026/Q3 +498,980 3.8%
Deep Track Capital, LP VC/PE Fund 2026/Q3 +460,224 10.6%
Norges Bank Investment Management Sovereign Wealth Fund 2026/Q3 +426,977 0.6%
Bank of America Corporation Public Company 2026/Q3 +336,747 0.7%
Davern Capital Partners, LP Hedge Fund 2026/Q3 +319,598 0.6%
Deerfield Management Company, L.P. Hedge Fund 2026/Q3 +318,007 1.5%
HongShan Capital Advisors Limited VC/PE Fund 2026/Q3 +254,750 0.4%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
20 Sep 2026 Blai Coll Chief Medical Officer Other Disposition -4,008 – 15,098
20 Sep 2026 Blai Coll Chief Medical Officer Other Derivative Acquisition +4,008 – 5,165
20 Sep 2026 Blai Coll Chief Medical Officer Open Market Derivative Dispositi -4,008 – 1,157
17 Sep 2026 Blai Coll Chief Medical Officer Sale to Issuer -3,542 $35.01 15,098
31 Aug 2026 Xichen Lin Chief Scientific Officer & GM of Structure Shanghai Derivative Exercise and Sale -17,817 – 53,578
31 Aug 2026 Xichen Lin Chief Scientific Officer & GM of Structure Shanghai Derivative Exercise and Sale -5,939 $47.83 –
17 Aug 2026 Xichen Lin Chief Scientific Officer & GM of Structure Shanghai Derivative Exercise and Sale -11,817 – 53,578
17 Aug 2026 Xichen Lin Chief Scientific Officer & GM of Structure Shanghai Derivative Exercise and Sale -3,939 $55.05 –
5 Aug 2026 John Berrios Other Acquisition +140,766 – 140,766
5 Aug 2026 John Berrios Other Derivative Acquisition +174,612 $17.54 174,612
3 Aug 2026 Xichen Lin Chief Scientific Officer & GM of Structure Shanghai Derivative Exercise and Sale -11,817 – 53,578
3 Aug 2026 Xichen Lin Chief Scientific Officer & GM of Structure Shanghai Derivative Exercise and Sale -3,939 $50.03 –
13 Jul 2026 Xichen Lin Chief Scientific Officer & GM of Structure Shanghai Other Acquisition +7,878 – –
13 Jul 2026 Xichen Lin Chief Scientific Officer & GM of Structure Shanghai Open Market Disposition -7,878 $51.71 –
13 Jul 2026 Xichen Lin Chief Scientific Officer & GM of Structure Shanghai Derivative Exercise and Sale -23,634 – 53,578
13 Jul 2026 Xichen Lin Chief Scientific Officer & GM of Structure Shanghai Other Derivative Acquisition +7,878 – 7,878
13 Jul 2026 Xichen Lin Chief Scientific Officer & GM of Structure Shanghai Open Market Derivative Dispositi -7,878 – –
24 Jun 2026 Xichen Lin Chief Scientific Officer & GM of Structure Shanghai Other Acquisition +7,878 – –
24 Jun 2026 Xichen Lin Chief Scientific Officer & GM of Structure Shanghai Open Market Disposition -7,878 $49.08 –
24 Jun 2026 Xichen Lin Chief Scientific Officer & GM of Structure Shanghai Derivative Exercise and Sale -23,634 – 53,578

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 5,927,622 8.3% 6.5
15 Oct 2026 7,147,328 10.0% 4.8
30 Sep 2026 7,540,480 10.6% 5.2
15 Sep 2026 6,605,011 9.3% 5.2
31 Aug 2026 5,854,907 8.2% 7.9
14 Aug 2026 6,079,970 8.5% 10.4

Discussion

No comments yet — be the first to weigh in on GPCR.

Sign in to join the discussion.

Scroll to Top